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Background and Purpose 18 
Sperm from many species share the sperm-specific Ca
2+
 channel CatSper (cation channel of 19 
sperm) that controls the intracellular Ca
2+
 concentration and, thereby, the swimming 20 
behaviour. A growing body of evidence suggests that the mechanisms controlling CatSper 21 
activity and the role of the channel during fertilization differ among species. However, a lack 22 
of suitable pharmacological tools has hampered the elucidation of the function of CatSper. 23 
Known CatSper inhibitors exhibit considerable side effects and inhibit also Slo3, the K
+
 24 
channel in mammalian sperm.  25 
Experimental Approach 26 
The drug RU1968 was reported to suppress Ca
2+
 signaling in human sperm by an unknown 27 
mechanism. We resynthesized the drug and revisited its mechanism of action in sperm form 28 
humans, mice, and sea urchins.  29 
Key Results 30 
We show by Ca
2+
 fluorimetry, single-cell Ca
2+
 imaging, electrophysiology, opto-chemistry, 31 
and motility analysis that RU1968 inhibits CatSper in sperm from invertebrates and 32 
mammals. The drug lacks toxic side effects in human sperm, does not affect mouse Slo3, and 33 
inhibits human Slo3 with about 15-fold lower potency than CatSper. Moreover, in human 34 
sperm, the inhibitor mimics CatSper dysfunction and suppresses motility responses evoked by 35 
progesterone, an oviductal steroid that activates CatSper. Finally, we show that the drug 36 
abolishes CatSper-mediated chemotactic navigation in sea urchin sperm. 37 
Conclusion and Implications 38 
We propose RU1968 as a novel tool to elucidate the function of CatSper in sperm across 39 
species. 40 
Non-standard abbreviations 41 
2-AG  2-arachidonoylglycerol (2-AG)  42 
ABHD2 alpha/beta hydrolase domain-containing protein 2  43 
ASW  artificial sea water 44 
BSA  bovine serum albumin  45 
[Ca
2+
]i  intracellular Ca
2+
 concentration 46 
CASA  computer-assisted sperm analysis 47 
CatSper cation channel of sperm 48 
CI  confidence interval  49 
F  fluorescence 50 
HC  HC-056456 51 
HSA  human serum albumin 52 
HTF  human tubal fluid 53 
LED  light-emitting diode  54 
MDL  MDL 12330A 55 
NNC  NNC 0936 56 
PGE1  prostaglandin E1 57 
pHi  intracellular pH 58 
RT  room temperature 59 
sEBSS  supplemented Earle´s balanced salt solution 60 
Slo3  slowpoke channel isoform 3 61 
TYH   Toyoda, Yokoyama and Hosi´s medium 62 
UV  ultraviolet light 63 
VAP  velocity average path  64 
Vm  membrane potential 65 
 66 
 67 
 68 
Introduction 69 
The intracellular Ca
2+
 concentration ([Ca
2+
]i) modulates the beat of the sperm 70 
flagellum and, thereby, the swimming behavior (Alvarez et al., 2014, Publicover et al., 2008). 71 
In many but not all species, [Ca
2+
]i is controlled by the sperm-specific CatSper Ca
2+
 channel  72 
(Lishko et al., 2010, Ren et al., 2001, Kirichok et al., 2006, Quill et al., 2001, Seifert et al., 73 
2015, Loux et al., 2013). CatSper appeared early in evolution, before the branching of 74 
eukaryotes into unikonts and bikonts (Cai and Clapham, 2008, Chung et al., 2017, Cai et al., 75 
2014). So far, most of our knowledge about CatSper originates from physiological studies of 76 
native channels in mammalian and sea urchin sperm. In general, CatSper is activated by 77 
depolarization of the membrane potential (Vm) and by alkalization of the intracellular pH 78 
(pHi) (Lishko et al., 2011, Lishko et al., 2010, Kirichok et al., 2006, Strünker et al., 2011, 79 
Seifert et al., 2015). In sea urchin sperm, the egg´s chemoattractant evokes rapid changes in 80 
Vm and pHi and, thereby, stimulates Ca
2+
 influx via CatSper (Seifert et al., 2015, Espinal-81 
Enriquez et al., 2017); the chemoattractant-evoked Ca
2+ 
influx controls chemotactic steering. 82 
Targeted ablation of genes encoding CatSper subunits provided insight into the function of 83 
CatSper in mouse sperm (Chung et al., 2017, Chung et al., 2011, Wang et al., 2009, Liu et al., 84 
2007, Carlson et al., 2003, Ren et al., 2001, Quill et al., 2001, Carlson et al., 2005, Qi et al., 85 
2007, Zeng et al., 2013): mouse CatSper
-/-
 sperm suffer from impaired motility (Qi et al., 86 
2007, Ren et al., 2001, Miki and Clapham, 2013), fail to traverse the oviduct (Ho et al., 2009, 87 
Chung et al., 2014, Miki and Clapham, 2013), and are unable to penetrate the egg coat (Ren et 88 
al., 2001), resulting in male infertility (Qi et al., 2007, Quill et al., 2001, Ren et al., 2001). 89 
CatSper is essential for fertilization also in humans: mutations in CATSPER genes (Avenarius 90 
et al., 2009, Hildebrand et al., 2010) and CatSper dysfunction (Williams et al., 2015) are 91 
associated with male infertility. However, mouse and human CatSper have distinct properties, 92 
indicating that the channel might serve various different functions (Alvarez, 2017, Kaupp and 93 
Strünker, 2016). For example, in human but not in mouse sperm, CatSper serves as a 94 
polymodal sensor that integrates diverse chemical cues (Brenker et al., 2018, Schiffer et al., 95 
2014, Brenker et al., 2012): human CatSper is activated by progesterone and prostaglandins 96 
(Brenker et al., 2012, Lishko et al., 2011, Strünker et al., 2011), two hormones present in the 97 
oviductal fluid (Schuetz and Dubin, 1981). The ensuing Ca
2+
 influx controls the swimming 98 
behaviour and promotes the penetration of the egg coat (Schaefer et al., 1998, Harper et al., 99 
2003, Publicover et al., 2008, Oren-Benaroya et al., 2008, Baldi et al., 2009, Tamburrino et 100 
al., 2015, Tamburrino et al., 2014, Alasmari et al., 2013a, Kilic et al., 2009, Schiffer et al., 101 
2014). Moreover, progesterone facilitates the migration of human sperm in viscous medium 102 
encountered by the sperm during their voyage across the female genital tract (Alasmari et al., 103 
2013b). However, in humans, neither the role of CatSper nor that of progesterone and 104 
prostaglandins during fertilization has been fully established. The function of CatSper in 105 
species other than sea urchin, mouse, and human is largely unknown. To address these 106 
questions, we rely on pharmacological tools that allow manipulating CatSper function. 107 
 Several drugs have been identified that suppress CatSper activity, for example NNC-108 
0396 (NNC) (Lishko et al., 2011, Strünker et al., 2011), Mibefradil (Strünker et al., 2011), 109 
MDL12330A (MDL) (Brenker et al., 2012), and HC-056456 (HC) (Carlson et al., 2009). In 110 
patch-clamp experiments, NNC, Mibefradil, and MDL abolish CatSper currents (Brenker et 111 
al., 2012, Lishko et al., 2011, Strünker et al., 2011); HC attenuates CatSper currents (Carlson 112 
et al., 2009), but it is unknown whether the drug inhibits the channel completely. Of note, 113 
none of these drugs is selective for CatSper: the drugs also inhibit the sperm-specific K
+
 114 
channel Slo3 (Carlson et al., 2009, Brenker et al., 2014, Navarro et al., 2007, Mansell et al., 115 
2014) - the principal K
+
 channel in mouse (Zeng et al., 2011, Santi et al., 2010) and human 116 
sperm (Brenker et al., 2014). Notably, each drug inhibits CatSper and Slo3 with similar 117 
potency. Moreover, NNC, Mibefradil, and MDL exhibit serious adverse actions in human 118 
sperm: at high micromolar concentrations required to abolish Ca
2+
 influx via CatSper, NNC 119 
and Mibefradil evoke a sizeable and sustained increase of [Ca
2+
]i and pHi (Strünker et al., 120 
2011, Brenker et al., 2012, Chavez et al., 2017) and stimulate acrosomal exocytosis (Chavez 121 
et al., 2017) (Figure S3). Similarly, MDL at high micromolar concentrations also evokes a 122 
sustained [Ca
2+
]i increase in human sperm (Brenker et al., 2012). Finally, the drugs affect the 123 
vitality and overall motility of sperm (Tamburrino et al., 2014) (Figure S3). HC has not been 124 
further characterized in human sperm, because it is not commercially available. In conclusion, 125 
novel potent and selective CatSper inhibitors without toxic side effects are required. 126 
Before the discovery of CatSper, the steroidal sigma-receptor ligand RU1968 was 127 
reported to suppress progesterone- and prostaglandin-induced Ca
2+
 signals in human sperm 128 
(Schaefer et al., 2000). The mechanism of RU1968 action in sperm has remained unclear, 129 
except that it does not involve the activation of sigma receptors (Schaefer et al., 2000). We 130 
wondered whether RU1968 might inhibit CatSper and revisited the drug´s action in sperm. 131 
We show that RU1968 potently abolishes CatSper-mediated Ca
2+
 signals in mouse, human, 132 
and sea urchin sperm. Patch-clamp recordings from mouse and human sperm corroborated 133 
that RU1968 inhibits CatSper. The drug does not affect mouse Slo3 and inhibits human Slo3 134 
with about 15-fold lower potency than human CatSper. When present during the capacitation 135 
process, RU1968 suppresses hyperactivation in human sperm. The drug also inhibits 136 
progesterone-evoked motility responses, showing that these involve Ca
2+
 influx via CatSper. 137 
Finally, we demonstrate that RU1968 abolishes chemotaxis of sea urchin sperm. In summary, 138 
RU1968 is a potent cross-species CatSper inhibitor that is selective for CatSper over Slo3. 139 
The drug seems well-suited to study CatSper function in sperm from invertebrates to 140 
mammals. 141 
 142 
Material and Methods 143 
 144 
Sperm preparation 145 
The studies involving human sperm were performed in agreement with the standards 146 
set by the Declaration of Helsinki. Samples of human semen were obtained from volunteers 147 
with their prior written consent. Approval of the institutional ethics committees of the medical 148 
association Westfalen-Lippe and the Medical Faculty of the University of Münster: 4INie; 149 
approval of the ethical committee of the University of Birmingham Life and Health Sciences: 150 
ERN12-0570R. For Ca
2+
 fluorimetry in sperm populations, single-cell Ca
2+
 imaging, patch-151 
clamp recordings, single-cell motility studies, and assays for acrosomal exocytosis and 152 
viability, sperm were purified by the swim-up procedure in human tubal fluid (HTF) medium 153 
containing (in mM): 93.8 NaCl, 4.69 KCl, 0.2 MgSO4, 0.37 KH2PO4, 2.04 CaCl2, 0.33 Na-154 
pyruvate, 21.4 lactic acid, 2.78 glucose, 21 HEPES, and 4 NaHCO3, pH 7.35 (adjusted with 155 
NaOH). Sperm were washed and re-suspended in HTF containing 3 mg/ml human serum 156 
albumin (HSA, Irvine Scientific, Santa Ana, CA, USA). For Kremer test, sperm were purified 157 
by the swim-up procedure in Supplemented Earle´s Balanced Salt Solution (sEBSS), 158 
containing (in mM): 98.5 NaCl, 5.4 KCl, 1.8 CaCl2, 1 MgCl2, 5.5 glucose, 25 NaHCO3, 2.5 159 
Na-pyruvate, 19 Na-lactate, 0.81 MgSO4, 15 HEPES, and 0.3% bovine serum albumin, pH 160 
7.4 (adjusted with NaOH). Before experiments, sperm were incubated for at least 300 min at 161 
37°C and 5% CO2 atmosphere. For computer-assisted sperm analysis (CASA), sperm were 162 
purified by the swim-up procedure in HTF lacking NaHCO3 and HSA. Sperm were washed 163 
and re-suspended in this medium (non-capacitating conditions) or in HTF fortified with 25 164 
mM NaHCO3 and 3 mg/ml HSA (capacitating conditions). Before experiments, sperm were 165 
incubated for at least 300 minutes at 37°C and 5% CO2 atmosphere.   166 
 C57BL/6N wildtype and C57BL/6N CatSper1
-/-
 mice were kept specific pathogen-free 167 
in ventilated cages (Greenline, Tecniplast). Maximally five mice were housed per cage and 168 
handled and sacrificed in accordance with the guideline set by the Animal Center of 169 
Nanchang University (Approval: SYXK2010-0002) and in accordance with the German 170 
Animal Welfare Act and the district veterinary office under approval by the LANUV 171 
(AZ.02.05.50.16.011 and AZ.84-02.04.2012.A192). Mouse epididymides were obtained from 172 
at least 15 weeks old male mice that were anaesthetized with CO2 or isoflurane (Abbvie 173 
Deutschland, Ludwigshafen, Germany) and sacrificed by cervical dislocation. For patch-174 
clamp recordings, sperm were isolated from the cauda epididymis by swim-out in HS solution 175 
containing (in mM): 135 NaCl, 5 KCl, 1 MgSO4, 2 CaCl2, 20 HEPES, 5 glucose, 10 lactic 176 
acid, 1 Na-pyruvate, pH 7.4 (adjusted with NaOH). After 20 min swim-out at 37 °C and 10% 177 
CO2, the supernatant was collected. Sperm were washed twice and re-suspended in HS 178 
solution. For Ca
2+
 fluorimetry, sperm were isolated by swim-out in TYH-medium containing 179 
(in mM): 138 NaCl, 4.8 KCl, 2 CaCl2, 1.2 KH2PO4, 1 MgSO4, 5.6 glucose, 0.5 Na-pyruvate, 180 
10 Na-lactate, 10 HEPES, pH 7.4 (adjusted with NaOH). After 15 min swim-out at 37 °C and 181 
5% CO2, sperm were counted and capacitated in TYH-medium supplemented with 25 mM 182 
NaHCO3 and 3 mg/ml BSA. 183 
Sperm from the sea urchin Arbacia punctulata were obtained by injecting 0.5 M KCl 184 
into the body cavity or electrical stimulation of the animal. The ejaculate (“dry sperm”) was 185 
diluted in artificial sea water (ASW) containing (in mM): 423 NaCl, 9.27 CaCl2, 9 KCl, 22.94 186 
MgCl2, 25.5 MgSO4, 0.1 EDTA, 10 HEPES, pH 7.8 (adjusted with NaOH). 187 
 188 
Measurement of changes in intracellular Ca
2+
 189 
In human sperm populations, changes in [Ca
2+
]i and pHi were measured with the 190 
fluorescent Ca
2+
 indicator Fluo4 and BCECF (Thermo Fisher, Waltham, MA, USA), 191 
respectively, in 384 multi-well plates in a fluorescence plate reader (Fluostar Omega, BMG 192 
Labtech, Ortenberg, Germany) at 29°C, or in a rapid-mixing device in the stopped-flow mode 193 
(SFM400, Bio-Logic, Grenoble, France) at 37°C. Sperm were loaded with Fluo4-AM (10 194 
µM) in the presence of Pluronic F-127 (0.05% w/v) at 37°C for 45 min or with BCECF-AM 195 
(10 µM) at 37°C for 15 min. After incubation, excess dye was removed by centrifugation (700 196 
x g, 10 min, room temperature (RT)). Sperm concentration was adjusted to 5 x 106 cells /ml 197 
in HTF and equilibrated for 5 min at 29°C (Fluostar) or 37°C (stopped-flow).  198 
In plate-reader experiments, wells were filled with 50 µl of the sperm suspension; the 199 
fluorescence was excited at 480 nm (Fluo-4) or 440 nm and 480 nm (dual excitation, BCECF) 200 
and fluorescence emission was recorded at 520 nm. Fluorescence was monitored before and 201 
after injection of 25 µl (1:3 dilution) RU1968F1, followed after 5 min by injection of stimuli 202 
(1:10 dilution). The solutions were injected into the wells with an electronic multichannel 203 
pipette. Changes in Fluo-4 fluorescence are depicted as ΔF/F (%), i.e. the change in 204 
fluorescence (ΔF) relative to the mean basal fluorescence (F) before application of buffer or 205 
stimuli, to correct for intra- and inter-experimental variations in basal fluorescence among 206 
individual wells. Changes in BCECF-fluorescence ratio (R, 480/440 nm) are depicted as 207 
ΔR/R (%), i.e. the change in ratio (ΔR) relative to the mean basal ratio (R) before application 208 
of buffer or stimuli, to correct for intra- and inter-experimental variations in the basal 209 
fluorescence ratio among individual wells. In stopped-flow experiments, the sperm 210 
suspension was rapidly mixed (1:1; flow rate = 1 ml/s) with HTF containing RU1968 and 211 
other stimuli, or with K8.6-, KCl-, or pHo8.6-HTF containing RU1968. Fluorescence was 212 
excited with a SpectraX Light Engine modulated at 10 kHz (Lumencor, Beaverton OR, USA) 213 
and passed through a 494/20 nm excitation filter (Semrock, Buffalo NY, USA). Emission was 214 
passed through a 536/40 nm filter (Semrock) and recorded with a photomultiplier (H9656-20; 215 
Hamamatsu Photonics, Hamamatsu, Japan). Signals were amplified with a lock-in amplifier 216 
(7230 DSP, Signal Recovery, Oak Ridge TN, USA) and recorded with a data acquisition pad 217 
(PCI-6221; National Instruments, Germany) and BioKine software v. 4.49 (Bio-Logic). K8.6-218 
HTF (in mM): 98.5 KCl, 0.2 MgSO4, 0.37 KH2PO4, 2.04 CaCl2, 0.33 Na-pyruvate, 21.4 lactic 219 
acid, 2.78 glucose, 21 TAPS, and 4 KHCO3, pH 8.6 (adjusted with KOH). KCl-HTF (in mM): 220 
98.5 KCl, 0.2 MgSO4, 0.37 KH2PO4, 2.04 CaCl2, 0.33 Na-pyruvate, 21.4 lactic acid, 2.78 221 
glucose, 21 HEPES, and 4 KHCO3, pH 7.35 (adjusted with KOH). pHo8.6-HTF (in mM): 222 
93.8 NaCl, 4.69 KCl, 0.2 MgSO4, 0.37 KH2PO4, 2.04 CaCl2, 0.33 Na-pyruvate, 21.4 lactic 223 
acid, 2.78 glucose, 21 TAPS, and 4 NaHCO3, pH 8.6 (adjusted with NaOH). Changes in Fluo-224 
4 fluorescence are depicted as ΔF/F (%), i.e. the change in fluorescence (ΔF) relative to the 225 
fluorescence (F) right after the mixing, to correct for intra- and inter-experimental variations 226 
in basal fluorescence. For single-cell Ca
2+
 imaging, sperm were incubated in the wells of 227 
PLL-coated Greiner Cellview glass slides with Fluo-4-AM (5 µM) for 30 min at 37°C, 228 
followed by another 15 min at room temperature to allow settling of sperm on the glass 229 
surface. Afterwards, the buffer was replaced twice with 90 µl of “fresh” HTF to remove 230 
excess extracellular dye. Progesterone and RU1968F1 were injected in a 1:10 dilution (10 µl) 231 
into the well and the ensuing changes in [Ca
2+
]i were observed under an Olympus IX73 232 
inverted microscope, equipped with a 20x/0.75 objective (U Plan S Apo, Olympus, Germany), 233 
coupled to an Andor Zyla 4.2 sCMOS camera (Andor Technology, Belfast, UK). Images were 234 
captured at 1 Hz. Changes in [Ca
2+
]i were determined from a region of interest around the 235 
head and neck of single sperm. Signals are displayed as F-F0/Fmax-F0; F0 is the mean 236 
fluorescence of ≥ 5 images before injection of RU1968F1 or progesterone, whereas Fmax is the 237 
peak fluorescence signal evoked by a subsequent injection of ionomycin. This procedure 238 
corrects for intra- and inter-experimental variations in resting [Ca
2+
]i and dye loading among 239 
individual sperm. 240 
 In mouse sperm populations, changes in [Ca
2+
]i were measured in sperm loaded with 241 
Cal520-AM (5 μM) (ATT Bioquest, USA) in the presence of Pluronic F-127 (0.02% w/v) for 242 
45 min at 37°C in TYH buffer. After loading, excess dye was removed by three 243 
centrifugations (700 x g, 7 min, RT). Recordings were performed using the stopped-flow 244 
apparatus as described above, but with mixing at a flow rate of 0.5 ml/s. K8.6-TYH (in mM): 245 
4.8 NaCl, 138 KCl, 2 CaCl2, 1.2 KH2PO4, 1 MgSO4, 5.6 glucose, 0.5 Na-pyruvate, 10 lactic 246 
acid, 10 TAPS, pH 8.6 (adjusted with KOH). 247 
 In sea urchin sperm populations, changes in [Ca
2+
]i were recorded in Fluo4-loaded 248 
sperm. To this end, dry sperm (diluted 1:6 (v/v)) were loaded with Fluo4-AM (10 μM) in the 249 
presence of Pluronic F-127 (0.02% w/v) for 45 min at 18°C in ASW. After loading, sperm 250 
were diluted 1:20 (v/v) in ASW and allowed to equilibrate for 5 min. Recordings were 251 
performed using the stopped-flow apparatus with a flow rate of 1 ml/s. Fluorescence was 252 
excited, recorded, and processed as described above. 253 
KCl-ASW (in mM): 216 KCl, 216 NaCl, 9.27 CaCl2, 22.94 MgCl2, 25.5 MgSO4, 0.1 EDTA, 254 
10 HEPES, pH 7.8, (adjusted with NaOH).  255 
  256 
Patch-clamp recordings 257 
Patch-clamp recordings from human sperm were performed in the whole-cell 258 
configuration, as previously described (Strünker et al., 2011). Seals between pipette and 259 
sperm were formed either at the cytoplasmic droplet or the neck region in standard 260 
extracellular solution (HS) containing (in mM): 135 NaCl, 5 KCl, 1 MgSO4, 2 CaCl2, 5 261 
glucose, 1 Na-pyruvate, 10 lactic acid, and 20 HEPES, pH 7.4 (adjusted with NaOH). CatSper 262 
currents were recorded in divalent-free solutions containing (in mM): 140 CsCl, 40 HEPES, 1 263 
EGTA, pH 7.4 (adjusted with CsOH); the pipette solution contained (in mM): 130 Cs-264 
aspartate, 50 HEPES, 5 EGTA, 5 CsCl, pH 7.3 (adjusted with CsOH). Slo3 currents were 265 
recorded in HS with a pipette solution containing (in mM): 140 K-aspartate, 50 HEPES, 10 266 
NaCl, 5 KCl, 0.5 CaCl2, pH 7.3 (adjusted with KOH). Hv1 currents were recorded in a bath 267 
and pipette solution containing (in mM): 120 NMDG, 100 MES, 5 TEA-Cl, 2 EGTA, pH 6 268 
(adjusted with methanesulfonic acid). To depict mean changes in CatSper currents, CatSper 269 
current amplitudes were normalized to that of the monovalent currents in the absence of any 270 
progesterone, NH4Cl, or RU1068F1. This procedure corrects for variations in amplitudes 271 
among individual sperm to ease and to improve the clarity of the graphical illustration. Patch-272 
clamp recordings from mouse sperm were performed in the whole-cell configuration, as 273 
previously described (Kirichok et al., 2006, Zeng et al., 2011). Seals between pipette and 274 
sperm were formed at the cytoplasmic droplet. For Slo3 recordings, the extracellular solution 275 
contained (in mM): 160 KOH, 10 HEPES, 150 MES, and 2 Ca(MES)2, adjusted to pH 7.4 276 
with MES; the pipette solution contained (in mM): 155 KOH, 5 KCl, 10 BAPTA, 20 HEPES, 277 
115 MES, pH 8.0 (adjusted with KOH). CatSper currents were recorded in divalent-free 278 
solutions containing (in mM): 150 NaCl, 20 HEPES, 5 EDTA, pH 7.4 (adjusted with NaOH); 279 
and with a pipette solution containing (in mM) 135 Cs-MES, 10 HEPES, 10 EGTA, and 5 280 
CsCl, pH 7.2 (adjusted with CsOH). Current amplitudes were normalized to that of the 281 
monovalent currents in the absence of NH4Cl or RU1968F1 (control) to correct for variations 282 
in amplitudes among individual sperm.   283 
Human T-type (Cav3.2) and L-type (CaV1.2+β2b+α2δ1) Ca
2+
 channels were studied in 284 
HEK293T cells (The European Collection of Cell Cultures, Porton Down, UK) that were 285 
cultured according to the supplier’s protocol in the presence of penicillin G (100 U/ml) and 286 
streptomycin (10 mg/ml). Cells were transfected at 40% confluency with pcDNA3.1-287 
CACNA1C, pcDNA3.1-CaVb2b, and pIRES-dsRed-CaVa2d1 in a ratio of 2:1:1 µg, or with 288 
2 µg of pCMV-Entry-CACNA1H, using the calcium-phosphate precipitation method. Patch-289 
clamp recordings from HEK293T cells were performed in the whole-cell configuration, using 290 
a HEKA EPC 10 amplifier with PatchMaster software (both HEKA Elektronik, Lambrecht, 291 
Germany). The extracellular solution contained (in mM): 125 TEA-Cl, 15 glucose, 10 292 
HEPES, 5 CaCl2, pH 7.4, (adjusted with CsOH); the pipette solution contained (in mM): 100 293 
CsCl, 10 EGTA, 10 HEPES, 5 TEA-Cl, 5 MgATP, 0.2 NaGTP, pH 7.4 (adjusted with CsOH). 294 
RU1968F1 was applied via a gravity-driven perfusion system.  295 
 296 
Analysis of sperm motility  297 
To evaluate the acute action of RU1968F1 on motility parameters, sperm from a 298 
particular sample were incubated side-by-side in HTF lacking NaHCO3 and HSA (non-299 
capacitating medium) and capacitating medium (25 mM NaHCO3 / 3 mg/ml HSA). After 3 300 
hours of incubation at 37°C, sperm kinematic parameters were analyzed by a CASA system 301 
(CEROS, Hamilton Thorn Research, Beverly, MA, USA) before and after application of 302 
RU1968F1. Sperm were bathed in RU1968F1 for 5 min prior to the experiment. To evaluate 303 
the long-term action of RU1968F1 on sperm motility parameters, sperm were re-suspended in 304 
capacitating medium (HTF containing 25 mM NaHCO3 and 3 mg/ml HSA) with or without 305 
RU1968F1. After 3 hours of incubation at 37°C, sperm kinematic parameters were analyzed 306 
by CASA. To evaluate the action of RU1968F1 on progesterone-induced hyperactivation, 307 
capacitated sperm were incubated for 5 min in the absence (control) and presence of 308 
progesterone, RU1968F1, and progesterone plus RU1968F1, and the motility was analyzed by 309 
CASA. The following parameters were determined by CASA: curvilinear velocity (VCL, 310 
µm/s), amplitude of lateral head displacement (ALH, µm), linearity of progression (LIN, %), 311 
percentage of total, progressive, and rapid motility as well as percentage of motile, 312 
hyperactivated sperm. The threshold values for hyperactivation were manually set (VCL >150 313 
mm/s, ALH>7 mm, LIN < 50% (Mortimer et al., 1998; Tamburrino et al, 2014). A minimum 314 
of 100 cells and 5 fields of view were analysed for each aliquot. The experiments were 315 
performed at 37°C. 316 
Motility in human sperm evoked by uncaging of progesterone were studied in an 317 
observation chamber (100 µm depth) under an Olympus IX71 inverted microscope (Olympus, 318 
Tokyo, Japan), equipped with a 4x microscope objective (0.13 NA, UPLFLN-PH, Olympus) 319 
under dark-field illumination (red LED, M660L3-C1, Thorlabs). Movies were recorded at a 320 
total magnification of 6.4x with a high-speed CMOS camera (Dimax HD, PCO, Kelheim, 321 
Germany) at 150 Hz. Photolysis of caged progesterone (1 µM) (Kilic et al., 2009) was 322 
achieved using a 200 ms light flash delivered by a 365 nm LED (M365L2-C, Thorlabs, 323 
Munich, Germany). Movies were processed and analyzed using a customized CASA 324 
(computer-assisted sperm analysis) plugin for ImageJ. Changes in the average path velocity 325 
(VAP) are depicted as VAP (%), i.e. the change in VAP relative to the VAP right before the 326 
UV flash, to correct for intra- and inter-experimental variations and for the different resting 327 
VAP in the absence and presence of the inhibitor. This procedure eases and improves the 328 
clarity of the graphical illustration. 329 
Kremer penetration assays were performed in sEBSS supplemented with 330 
methylcellulose (1% w/v) and 0.3% BSA, equilibrated overnight at 4°C (penetration 331 
medium). The penetration medium, with or without RU1968F1, was filled into flattened glass 332 
capillary tubes (dimensions: 1.2 x 4.8 x 50 mm, 400 µm depth; CM scientific, UK); one end 333 
of the tubes was sealed with CristaSeal wax (Hawksley, UK). The open ends of the tubes 334 
were submersed in a sperm suspension (3 x 10
6
 /ml) with or without stimuli and/or 335 
RU19868F1. Penetration was assessed after 1h (37°C, 5.5% CO2) by counting sperm at 2 cm 336 
using a phase contrast microscope at a 200x magnification. 3 fields of view were chosen and 337 
in each field, three focal planes were counted, yielding 9 fields altogether.  338 
Human sperm viability and motility as shown in Figure S3 was tested following 339 
incubation of sperm for 5 min at room temperature with RU1968F1, NNC-55-0396, 340 
Mibefradil, or the vehicle (DMSO). The fraction of immotile and dead sperm was assessed by 341 
counting and by an eosin vitality test, respectively, at 200x magnification under a phase-342 
contrast microscope (Axiostar, Carl Zeiss), in accordance with the WHO guidelines for semen 343 
analysis (WHO, 2010).  For the eosin staining, 5 µl of the sperm suspension was mixed with 5 344 
µl of eosin staining solution (0.5 % (w/v) eosin Y dissolved in a 0.9 % NaCl solution) on a 345 
microscope slide, covered with a 22 x 22 mm coverslip, and incubated for 30 s at room 346 
temperature. Eosin-positive (dead) vs. eosin-negative (live) sperm were counted. To 347 
determine the fraction of immotile and viable sperm, a total number of 400 sperm was 348 
assessed. 349 
Sea urchin sperm chemotaxis was studied as described (Seifert et al., 2015). In brief, 350 
sperm (~ 10
8
 cells/ml) were observed in a recording chamber (150 μm depth) under an IX71 351 
microscope (Olympus), equipped with a 10x microscope objective (UPlanSApo; NA 0.4; 352 
Olympus), with stroboscopic (500 Hz) dark-field illumination (white LED; K2 star; Luxeon). 353 
Movies were recorded with an EMCCD camera (DU‐897D; Andor) at 20 Hz through a 354 
bandpass filter (HQ520/40; Chroma). Photolysis of caged resact was achieved using a 200 ms 355 
pulse from a 365 nm LED (M365L2-C, Thorlabs). The relative dispersion was calculated as 356 
described before (Seifert et al., 2015). 357 
 358 
Acrosomal exocytosis 359 
Human sperm, capacitated for at least 300 min, were incubated with either 0.1% 360 
DMSO (vehicle control), RU1968F1 (10 µM), progesterone (10 µM), or a mixture of both (10 361 
µM each) for 1 h at 37°C. Afterwards, sperm were washed by centrifugation and re-suspended 362 
in 0.5 ml of hypo-osmotic swelling medium (WHO, 2010). After 1 h at 37°C, sperm were 363 
washed again and fixed in 50 µl ice-cold methanol. The sperm were layered on a slide, air-364 
dried, and stored at -20°C. For acrosome staining, sperm were incubated for 20 min in the 365 
dark with 1 mg/ml FITC-labeled Arachis hypogaea (peanut) lectin (PNA-FITC, Sigma 366 
Aldrich) in PBS. Slides were analyzed using an Axiolab A1 FL microscope (Carl Zeiss, Jena, 367 
Germany). For each condition, 200 curled-tail (viable) cells were analyzed for their acrosomal 368 
status, as previously described (Tamburrino et al., 2014).  369 
 370 
Data analysis and statistical evaluation 371 
The data analysis complies with the recommendations on experimental design and 372 
analysis in pharmacology (Curtis et al, 2015). All data are presented as mean ± standard 373 
deviation. Statistical analysis and fitting of dose-response relations were performed using 374 
GraphPad Prism 5 (Prism, La Jolla, USA). Half-maximal inhibitory concentrations (IC50) 375 
were derived by nonlinear regression analysis, using a four parameter fit: 376 
 𝑌 = bottom +  
(top−𝑏𝑜𝑡𝑡𝑜𝑚)
(1+10(𝑙𝑜𝑔𝐼𝐶50−𝑥)𝑛)
.  377 
Y = signal amplitude; bottom and top = plateaus in the units of Y; x = log(concentration of 378 
inhibitor); IC50 = concentration of agonist that gives the response half way between bottom 379 
and top; n = Hill coefficient.  380 
Most of the experiments were performed in a randomized block design, i.e. for each 381 
experimental replicate, sperm prepared from one particular semen sample were subjected in 382 
parallel to all treatment conditions. If the experiment involved two conditions (control and 383 
treatment), we used the paired t-test. If the experiment involved ≥ 3 conditions, we used one-384 
way randomized block ANOVA, assuming sphericity. When ANOVA´s F-test and the test for 385 
matching efficacy achieved P < 0.05, means were compared to the control´s mean by 386 
Dunnett’s multiple comparisons post-hoc test, unless otherwise indicated. If experiments were 387 
not performed in a randomized block design, we used unpaired t-test or one-way ANOVA; 388 
when ANOVA´s F-test achieved P < 0.05 and Bartlett’s test yielded no signiﬁcant variance 389 
inhomogeneity, means were compared to the control´s mean or to each other by Dunnett’s or 390 
Bonferron´s multiple comparisons post-hoc test, respectively. In Figure 6E, J, and Figure 8I, 391 
for the ease of illustration and for clarity, we show data normalized to the control. Yet, we 392 
normalized the data only after the statistical analysis using one-way ANOVA, because 393 
normalization makes any data set violate the ANOVA. 394 
 395 
Randomization and blinding 396 
Experiments and data analysis were performed without randomization and blinding, 397 
except for the Eosin test and the manual counting of motile/immotile sperm. Otherwise, non-398 
treated and treated conditions were measured and analyzed side-by-side by the same 399 
experimenter, using objective measures and analysis methods.  400 
 401 
Nomenclature of targets and ligands 402 
Key protein targets and ligands in this article are hyperlinked to corresponding entries 403 
in http://www.guidetopharmacology.org, the common portal for data from the IUPHAR/BPS 404 
Guide to PHARMACOLOGY (Harding et al., 2018), and are permanently archived in the 405 
Concise Guide to PHARMACOLOGY 2017/18 (Alexander et al., 2017a, b).  406 
 407 
Results 408 
Synthesis of RU1968  409 
 We synthesized RU1968 from (±) estrone methyl ether (Figure 1A, SI) that is readily 410 
accessible via the Torgov route (Ananchenko et al., 1962, Ananchenko and Torgov, 1963). 411 
Van Leusen reaction yielded the nitrile (1) (Van Leusen and Van Leusen, 2004), followed by 412 
addition of methyllithium to yield the ketone (2). Reductive amination with N, N-413 
dimethylethylenediamine established the aza side chain, yielding a mixture of four 414 
diastereomers (3) (at C-17 and C-20; Figure 1A, 3). We separated two diastereomers (Figure 415 
1A, compounds 3a and 3b), each a mixture of a cis and a trans isomer. Relative 416 
configurations (C-18 (CH3) and C-20 (CH)) were assigned by NMR spectroscopy (H,H-417 
COSY and NOE, Figure S1 and S2); the cis isomers were the dominant species (cis/trans 418 
ratio for compound 3a was 3:1; and for 3b it was 4:1). Finally, cleavage of the phenolic 419 
methyl ether yielded a diastereomeric mixture of RU1968. The diastereomers eluted from a 420 
preparative HPLC in four fractions called RU1968F1-4; RU1968F1 and 2 are derived from 3a 421 
cis and trans, respectively, whereas RU1968F3 and 4 are derived from 3b trans and cis, 422 
respectively (Figure 1C). Because the actions of RU1968F2-4 in sperm were similar to that of 423 
RU1968F1 (see Figure 2, S3, and S6), we chose RU1968F1 to characterize its action in 424 
sperm. We first examined the action of RU1968F1 in populations of human sperm loaded 425 
with a fluorescent pHi or Ca
2+
 indicator (Figure S3A-D). The drug evoked negligible changes 426 
in pHi. At concentrations ≤ 7.5 µM, RU1968F1 caused a small, transient Ca
2+
 increase; [Ca
2+
]i 427 
peaked and returned to basal levels within about 250 s. At concentrations > 7.5 µM, 428 
RU1968F1 evoked a slow decrease of [Ca
2+
]i. The mechanism(s) underlying the drug-evoked 429 
changes in [Ca
2+
]i are unclear; yet, in the absence of extracellular Ca
2+
, the drug did not 430 
change [Ca
2+
]i, indicating that Ca
2+
 release from internal stores is not involved (Figure S3C). 431 
Most importantly, even at high micromolar concentrations (30 µM), the drug did not affect 432 
overall human sperm motility and viability and did not evoke acrosomal exocytosis (Figure 433 
S3E-G). Thus, RU1968F1 lacks the toxic and adverse actions of NNC, Mibefradil, and MDL 434 
in human sperm.  435 
RU1968F1 is a potent cross-species CatSper inhibitor 436 
 To investigate whether RU1968F1 inhibits human CatSper, we studied progesterone- 437 
and PGE1-evoked Ca
2+
 signals in human sperm bathed in the drug. RU1968F1 slowed down 438 
and completely suppressed the Ca
2+
 signals in a dose-dependent fashion; the IC50 values of 4 439 
± 2 µM (progesterone) and 3.8 ± 0.5 µM (PGE1) (n = 7, mean ± SD) were similar to those 440 
reported previously (Schaefer et al., 2000) (Figure 2A-D). The drug was effective within a 441 
range of extracellular pH (pHo) values: at pHo 6.8 and 7.8, the IC50 value of the progesterone-442 
evoked Ca
2+
 signal was 4.4 ± 1.4 µM and 2.2 ± 0.6 µM, respectively (n = 6) (Figure 2B). The 443 
actions of RU1968F2-4 alone and on progesterone-induced Ca
2+
 signals were similar to those 444 
of RU1968F1 (see Figure 2, S3, and S6). 445 
 Furthermore, we studied whether RU1968F1 also inhibits Ca
2+
 signals evoked by 446 
intracellular alkalization via weak bases, e.g. NH4Cl (Figure 2E-G). The drug slowed down 447 
and almost completely suppressed Ca
2+
 signals evoked by NH4Cl ≤ 3 mM (Figure 2E, F); the 448 
IC50 value for 3 mM NH4Cl was 4.0 ± 2.8 µM (n = 5) (Figure 2F). Ca
2+
 signals evoked by 10 449 
mM NH4Cl were only slightly attenuated, whereas for 30 mM NH4Cl, the signal was rather 450 
similar in the absence and presence of RU1968F1. We conclude that RU1968F1 inhibits also 451 
ΔpHi-evoked Ca
2+
 responses; its potency seems to decrease with increasing ΔpHi. 452 
Alternatively, the presence of NH4
+
 or NH3 might impair binding of RU1968F1 to its blocking 453 
site. Arguing against that notion, the drug readily suppressed progesterone responses in sperm 454 
that were bathed for about 20 min in NH4Cl (30 mM) (Figure S5; IC50 = 3.5 ± 1.4 µM, n = 3); 455 
with time, the pHi slowly recovers from the NH4Cl-evoked alkalization (Strünker et al. 2011).  456 
 Influx of Ca
2+
 via CatSper can also be evoked by simultaneous extracellular 457 
alkalization (which increases pHi) and depolarization by K
+
 (K8.6 buffer) (e.g. Carlson et al., 458 
2003). RU1968F1 suppressed Ca
2+
 signals evoked by simultaneous 459 
alkalization/depolarization (Figure 2K, L; IC50 = 1.2 ± 0.6 µM, n = 3) and by alkalization or 460 
depolarization alone (Figure S4). Finally, when sperm were mixed simultaneously with 461 
progesterone and RU1968F1 in a stopped-flow apparatus, the inhibition of Ca2+ responses was 462 
similar to that under pre-incubation conditions (Figure 2I, J) (IC50 = 3.0 ± 1.1 µM; n = 4). 463 
This result suggests that RU1968F1 rapidly reaches its blocking site. 464 
Next, we studied the action of RU1968F1 in single human sperm by Ca
2+
 imaging. At 465 
concentrations ≥ 10 µM, RU1969F1 evoked a slow decrease of [Ca2+]i (Figure 3A); For low 466 
micromolar RU1969F1 concentrations, we did not observe Ca
2+
 transients, which might 467 
reflect differences in sensitivity of population versus single-cell fluorimetry. In the presence 468 
of RU1968F1, progesterone-induced Ca
2+
 responses were suppressed in a dose-dependent 469 
fashion (Figure 3B-D) with an IC50 of 4.8 ± 1.2 µM (standard error of the fit). Altogether, the 470 
action of the RU1868F1 itself on [Ca
2+
]i and on progesterone-evoked Ca
2+
 responses is 471 
similar when investigated in sperm populations and in single sperm.  472 
We further tested whether the drug also inhibits Ca
2+
 influx via CatSper in mouse 473 
sperm. Mouse CatSper is insensitive to progesterone and prostaglandins (Lishko et al., 2011). 474 
Therefore, we activated CatSper via simultaneous alkalization/depolarization or via 8-Br-475 
cAMP, which activates mouse (Ren et al., 2001) and human (Brenker et al., 2012) CatSper at 476 
high concentrations. RU1968F1 suppressed Ca
2+
 responses evoked by 477 
alkalization/depolarization or 8-Br-cAMP with an IC50 of 0.83 ± 0.07 µM and 0.84 ± 0.03 478 
µM, respectively (n = 3) (Figure 4A-D).  479 
Finally, we investigated the action of RU1968F1 on CatSper in sperm of the sea 480 
urchin Arbacia punctulata. To this end, we studied CatSper-mediated Ca
2+
 responses evoked 481 
either by the chemoattractant resact, depolarization of Vm, or by NH4Cl. Irrespective of the 482 
stimulus, RU1986F1 suppressed the Ca
2+
 responses with IC50 values of 1.3 ± 0.1, 1.1 ± 0.4, 483 
and 4 ± 2, respectively (n = 3) (Figure 5A-F). Altogether, these results suggest that 484 
RU1968F1 is a potent cross-species CatSper inhibitor.                         485 
To scrutinize this conclusion by an independent technique, we recorded by whole-cell 486 
patch-clamping CatSper currents in human and mouse sperm. In human sperm, monovalent 487 
CatSper currents were evoked by stepping the membrane voltage from –100 mV to +150 mV 488 
in increments of 10 mV from a holding potential of 0 mV. RU1968F1 completely suppressed 489 
the currents with an IC50 of 0.4 ± 0.3 µM (n = 5) (Figure 6A, B). Superfusion with 490 
progesterone or NH4Cl enhanced the current amplitudes (Fig, 6C, D). The progesterone- and 491 
NH4Cl-evoked currents were either completely suppressed or strongly attenuated by 492 
RU1968F1 (Figure 6C-E). In mouse sperm, monovalent CatSper currents were evoked by 493 
ramping the membrane voltage between -100 and +100 mV from a holding potential of 0 mV. 494 
Superfusion with RU1968F1 completely suppressed the currents with an IC50 of 10 ± 1 µM 495 
(Figure 6F, G). CatSper currents evoked at pHi 8 and by NH4Cl were strongly attenuated by 496 
the drug (Figure 6H-J). Thus, RU1968F1 inhibits human and mouse CatSper at rest and upon 497 
activation by ligands and ΔpHi. Similar to the results obtained by Ca
2+
 fluorimetry, the 498 
potency of the drug seems to decrease with increasing pHi. We did not test whether higher 499 
RU1968F1 concentrations completely suppress the currents evoked by NH4Cl and at pHi 8. 500 
 501 
RU1968F1 inhibits human but not mouse Slo3  502 
We studied the interaction of RU1968F1 with sperm ion channels other than CatSper. 503 
In mouse sperm, currents carried by the K
+
 channel Slo3 were similar in the absence and 504 
presence of RU1968F1 (Figure 7A, B). By contrast, in human sperm, the Slo3 current was 505 
inhibited with an IC50 of 7 ± 6 µM (n = 4) (Figure 7C, D). Thus, although not perfectly 506 
selective for CatSper, about 15-fold higher RU1968F1 concentrations are required to block 507 
human Slo3 channels. At concentrations up to 10 µM, the drug does not inhibit the voltage-508 
gated proton channel Hv1 and the ATP-gated P2X channel (Figure S7), which are expressed 509 
in human and mouse sperm, respectively (Navarro et al., 2011, Lishko et al., 2010). We 510 
conclude that in mouse sperm, RU1968F1 acts rather selectively on CatSper. In human sperm, 511 
the drug inhibits also Slo3, yet, with about 15-fold lower potency. Finally, RU1968F1 512 
inhibited heterologously expressed L- and T-type Ca
2+
 channels with IC50 values of about 20 513 
and 10 µM, respectively (Figs. S9, S10), indicating that the drug acts with lower potency also 514 
on classic voltage-gated Ca
2+
 channels of somatic cells. 515 
                                  516 
RU19681F1 suppresses progesterone-evoked motility responses in human sperm 517 
 Next, we tested the action of RU1968F1 on the motility of human sperm using 518 
classical computer-assisted sperm analysis (CASA). A brief incubation (5 min) of non-519 
capacitated or capacitated sperm with the drug did not impair overall motility (Figure 8A, B, 520 
black), whereas the fraction of progressively motile sperm decreased about twofold with 521 
increasing RU1968F1 concentrations (Figure 8A, B, blue). Whether this is due to the 522 
inhibition of CatSper or represents an adverse action of the drug is unclear.  523 
 Furthermore, the penetration of the egg coat requires hyperactivated motility, which is 524 
characterized by an asymmetric flagellar beat, lower beating frequency, wiggly swimming 525 
trajectory, and lower average path velocity (VAP) (Suarez, 2008). In mouse sperm, CatSper is 526 
required for hyperactivation (Ren et al., 2001), whereas the control of hyperactivation by 527 
CatSper in human sperm is debated (Tamburrino et al., 2014, Alasmari et al., 2013b). We 528 
studied whether RU1968F1 affects hyperactivation in human sperm. A brief incubation (5 529 
min) of capacitated sperm with RU1968F1 did not suppress spontaneous hyperactivated 530 
swimming. In fact, RU1968F1 concentrations ˂ 10 µM seem to slightly enhance 531 
hyperactivation, whereas higher drug concentrations had no effect (Figure 8B, green). 532 
Spontaneous hyperactivation develops during the capacitation process (compare Figure 8A 533 
and B, green). In sperm that were capacitated in the presence of RU1968F1 (10 µM), i.e. 534 
incubated for some hours under capacitating conditions, the drug suppressed spontaneous 535 
hyperactivation (Figure 8C); the fraction of progressively motile sperm or overall motility 536 
was not affected (Figure 8D, E). This result suggests that, in human sperm, CatSper is 537 
involved in the ability to undergo hyperactivation; though, the partial inhibition of Slo3 might 538 
contribute to this action of RU1968F1.  539 
 Finally, we studied the action of RU1968F1 on progesterone-induced changes in 540 
swimming behavior. Incubation of capacitated sperm with progesterone seemingly promoted 541 
hyperactivation, which was inhibited by RU1968F1 (Figure 8F); the effect of progesterone 542 
was, however, not statistically significant. Therefore, we studied the motility of human sperm 543 
before and after rapid activation of CatSper using caged progesterone (Kilic et al., 2009). 544 
Uncaging of progesterone by a brief (200 ms) UV flash instantaneously evoked a wiggly 545 
swimming trajectory (Figure 8G) and a decrease of VAP (Figure 8G, I), reminiscent of 546 
hyperactivated motility. The VAP reached its minimum ~5 s after uncaging of progesterone 547 
and did not recover within the recording time of 10 s. In the presence of RU1968F1, the 548 
swimming trajectory and the swimming pattern and VAP remained unchanged upon uncaging 549 
of progesterone (Figure 8H, I). We conclude that progesterone-evoked hyperactivation 550 
requires Ca
2+
 influx via CatSper.  551 
Furthermore, it is well established that progesterone facilitates the migration of human 552 
sperm into viscous medium (Alasmari et al., 2013b). In sperm from an infertile man lacking 553 
functional CatSper channels, this facilitation was abolished (Williams et al., 2015). Using a 554 
modified Kremer's sperm-mucus penetration test, we investigated whether CatSper inhibition 555 
by RU1968F1 recapitulates this phenotype. To this end, an open glass capillary, which 556 
contained medium fortified with methylcellulose, was submersed in a sperm suspension. The 557 
number of sperm at a penetration distance of 2 cm (Figure 9A-C) was determined; data for 558 
shorter or longer penetration distances are presented in Figure S8.  Consistent with previous 559 
results (Alasmari et al., 2013b), bathing sperm in progesterone enhanced the number of sperm 560 
penetrating the viscous medium (Figure 9A, C; S8A, C). The progesterone action was 561 
abolished by 1 µM RU1968F1 (Figure 9A, S8A). Of note, at this concentration, the drug itself 562 
did not affect the number of penetrating cells (Figure 9B, S8B). The progesterone action was 563 
also abolished when RU1968F1 was added to the capillary medium instead of to the sperm 564 
suspension (Figure 9C, S8C). These results support the notion that progesterone acts via 565 
CatSper to promote swimming in high-viscosity media and shows that RU1968F1 mimics the 566 
lack of functional CatSper channels. Of note, at concentrations > 1 µM, RU1968F1 in a dose-567 
dependent fashion lowered the number of penetrating sperm both in the absence and presence 568 
of progesterone (Figure 9A, B; S8A, B); this probably reflects the drug-related decrease of the 569 
fraction of progressively motile sperm.  570 
Incubation of human sperm in high micromolar concentrations of progesterone evokes 571 
acrosomal exocytosis (Baldi et al., 2009) (Figure 9D), i.e. the release of proteolytic enzymes 572 
from a secretory vesicle in the sperm head. In the presence of RU1968F1, the progesterone 573 
action was attenuated (Figure 9D), whereas RU1968F1 itself did not evoke acrosomal 574 
exocytosis (Figure 9D, S3). These results suggest that the progesterone-induced acrosome 575 
reaction involves Ca
2+ 
influx via CatSper and that RU1968F1 might allow unraveling the role 576 
of CatSper in this process in more detail. Altogether, we conclude that RU1968F1 can provide 577 
important insight on the role of progesterone action on CatSper to control various sperm 578 
functions.  579 
RU19681F1 inhibits chemotaxis of sea urchin sperm 580 
Finally, we tested whether RU1968F1 affects CatSper-mediated chemotactic steering 581 
of sea urchin sperm. In a shallow observation chamber under a dark-field microscope, sperm 582 
were bathed in a caged derivative of the chemoattractant resact (Alvarez et al., 2012, Böhmer 583 
et al., 2005, Kaupp et al., 2003). A chemoattractant gradient was established by photolysis of 584 
caged resact via a UV flash in the center of the recording chamber (Figure 10A). After the 585 
flash, sperm accumulated in the irradiated area, indicated by a decrease of sperm dispersion in 586 
the field of view (Figure 10B); the accumulation was abolished by RU1968F1 (Figure 10), but 587 
the drug did not affect the overall motility of the sperm.  588 
            589 
Discussion 590 
Here, we introduce RU1968F1 as a new pharmacological tool to elucidate the 591 
presence and role of CatSper in sperm. RU1968F1 is superior to hitherto known inhibitors: 592 
the drug is rather selective for CatSper and lacks toxic side effects in human sperm. Yet, 593 
because the action of the drug is complex, we cannot exclude adverse actions in other sperm 594 
species. This cautious note has to be considered in future studies using RU1968F1.  595 
What is the molecular mechanism underlying CatSper inhibition by RU1968F1? It has 596 
been proposed that progesterone acts via an endocannabinoid-signaling pathway, involving 597 
the receptor alpha/beta hydrolase domain-containing protein 2 (ABHD2) (Miller et al., 2016): 598 
at rest, CatSper is inhibited by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the 599 
flagellar membrane. Upon progesterone binding, ABHD2 degrades 2-AG and, thereby, 600 
relieves CatSper from inhibition (Miller et al., 2016). Considering that RU1968F1 is a steroid, 601 
the drug might act as an antagonist at the steroid-binding site on ABHD2. However, CatSper 602 
activation by prostaglandins does not involve ABHD2 (Miller et al., 2016), and in mouse and 603 
sea urchin sperm, CatSper is not activated by progesterone or prostaglandins (Lishko et al., 604 
2011, Seifert et al., 2015). Moreover, CatSper activation by alkaline pHi and depolarization 605 
does probably not involve a ligand-binding site. Therefore, we suspect that RU1968F1 binds 606 
to residues in the pore region and, thereby, directly block ion flux. The drug´s inhibitory 607 
action on classical voltage-gated Ca
2+
 channels also supports this conclusion. Of note, the 608 
potency of RU1968F1 to inhibit activation of CatSper by alkalization seems to decrease with 609 
increasing amplitude of ΔpHi. This might reflect a pH sensitivity of the blocking mechanism 610 
or pH-dependent distribution of the drug across membranes. The latter is rather unlikely: upon 611 
rapid mixing, the drug blocks Ca
2+
 influx via CatSper without a measurable latency, 612 
suggesting that the drug acts rather from the outside. However, the mechanism of CatSper 613 
inhibition will be difficult to elucidate rigorously by structure-function analysis or site-614 
directed mutagenesis, because CatSper resists functional expression.  615 
What is the nature of the blocking site in Slo3 in human sperm? Human, but not 616 
mouse Slo3, is inhibited by micromolar concentrations of progesterone (Brenker et al., 2014). 617 
This inhibition results from binding of progesterone either to a site on the channel itself or on 618 
its accessory subunit LRRC52 (Brenker et al., 2014). RU1968F1 might act via this steroid-619 
binding site on human Slo3. To improve the inhibitor´s selectivity, a structure-activity 620 
analysis is required to identify RU1968F1 derivatives that do not act on human Slo3, but 621 
display a similar or even enhanced potency to inhibit CatSper. The fact that human Slo3 can 622 
be functionally expressed in cultured cells (Brenker et al., 2014) facilitates this endeavor.  623 
Although the make-up of Ca
2+
-signaling pathways in sperm is quite diverse (Kaupp 624 
and Strünker, 2016, Alvarez, 2017), the CatSper channel is a common component in many, 625 
but not all species (Cai et al., 2014). Our finding that RU1968F1 inhibits CatSper across 626 
species opens the possibility to use the drug in diverse experimental settings. First, teleost fish 627 
seem to lack CatSper genes (Cai and Clapham, 2008), yet, the swimming behavior of 628 
zebrafish is controlled by Ca
2+
 (Fechner et al., 2015). However, the absence of CatSper in fish 629 
has been contested (Yanagimachi et al, 2017). RU1968F1 might help to solve this 630 
controversy. Second, the genome of many marine species, including the saprophytic fungus 631 
Allomyces macrogynus, the tunicate Ciona intestinalis, and the seastar Asterias amurensis 632 
harbor CatSper genes (Cai and Clapham, 2008, Cai et al., 2014). Sperm from these species 633 
also undergo chemotaxis (Matsumoto et al., 2003, Miller, 1975, Pommerville, 1978, Yoshida 634 
et al., 2002). RU1968F1 might reveal whether chemotaxis involves CatSper. Third, the drug 635 
might help to define the diverse CatSper functions among mammalian sperm. For example, 636 
mouse sperm undergo rotational motion that governs rheotaxis in gradients of flow velocities 637 
(Miki and Clapham, 2013). By contrast, CatSper
-/-
 mouse sperm do not rotate and fail to 638 
undergo rheotaxis, suggesting that Ca
2+
 influx via CatSper is required. However, another 639 
study describes rheotaxis as a passive process that does not require Ca
2+
 influx (Zhang et al., 640 
2016). CatSper recruits several proteins into Ca
2+
-signaling domains that form a quadrilateral 641 
arrangement along the flagellar membrane (Chung et al., 2014, Chung et al., 2017). Targeted 642 
deletion of CatSper subunits disrupts these signaling domains (Chung et al., 2014, Chung et 643 
al., 2017). Therefore, the motility defects of CatSper
-/-
 mouse sperm might be caused by the 644 
lack of Ca
2+
 influx via CatSper, by disruption of the supramolecular flagellar ultrastructure, or 645 
by a combination of both. Fourth, in human sperm, neither the role of oviductal CatSper 646 
ligands, nor the role of CatSper during fertilization has been fully established. This is due to 647 
the demanding challenge to mimic the complex chemical, hydrodynamic, and topographical 648 
environment of the oviduct in vitro (Xiao et al., 2017). We envision the use of RU1968F1 as a 649 
tool to study the role of CatSper and its ligands in human sperm navigating across artificial or 650 
explanted oviducts. 651 
Finally, mutations in CATSPER genes (Avenarius et al., 2009, Hildebrand et al., 2010) 652 
and the lack of functional CatSper channels (Williams et al., 2015) are associated with male 653 
infertility. In human sperm, at least in vitro, RU1968F1 mimics the lack of CatSper, 654 
indicating that inhibition of CatSper in vivo might prevent fertilization. Thus, RU1968F1 655 
could serve as a lead structure to develop new non-hormonal contraceptives. Drugs that 656 
specifically target CatSper should exhibit no side effects, because the expression of the 657 
channel is confined to sperm.  658 
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Figure legends 858 
 859 
Figure 1: Synthesis of RU1968F1-F4 (A) Synthesis of RU1968. Carbon atoms referred to in the text are 860 
marked with circles. (B) Structure of RU1968. (C) HPLC-elution profile of the four diastereomers. Isomers are 861 
named according to their order of elution. 862 
 863 
Figure 2: Action of RU1968F1 on CatSper-mediated Ca
2+
 signals in human sperm populations. (A) 864 
Progesterone-induced Ca
2+
 signals in human sperm in the absence and presence of RU1968F1. ΔF/F (%) 865 
indicates the percentage change in fluorescence (ΔF) with respect to the mean basal fluorescence (F) before 866 
application of progesterone (500 nM). (B) Dose-response relation for the maximal signal amplitudes of the data 867 
from (A) (pH 7.35) (IC50 = 5.5 μM) and of progesterone responses studied at an extracellular pH of 6.8 (IC50 = 868 
4.2 µM) or 7.8 (IC50 = 2.6 µM). (C) PGE1-induced Ca
2+
 signals in human sperm in the absence and presence of 869 
RU1968F1; PGE1 = 500 nM. (D) Dose-response relation for the maximal signal amplitudes of the data from (C) 870 
(IC50 = 3.1 μM). (E) NH4Cl-induced Ca
2+
 signals in the absence and presence of RU1968F1, NH4Cl = 3 mM. (F) 871 
Dose-response relation for the maximal signal amplitude of the data from (E) (IC50 = 1.8 μM) (G) Ca
2+
 signals 872 
evoked by various NH4Cl concentrations in the absence (control) and presence of RU1968F1 (30 µM). (H) Mean 873 
relative amplitude of Ca
2+
 signals evoked by various NH4Cl concentrations in the presence of RU1968F1 874 
(30µM) (n = 5); amplitude evoked in the absence of RU1968F1 = 1 (control). Error bars indicate SD. *P ˂ 0.05 875 
versus control. (I) Ca
2+
 signals evoked by simultaneous mixing of sperm with progesterone (500 nM) and 876 
RU1968F1 in a stopped-flow apparatus. ΔF/F (%) indicates the percentage change in fluorescence (ΔF) with 877 
respect to the fluorescence (F) immediately after mixing. (J) Dose-response relation of the data from (I) (IC50 = 878 
2.4 μM). (K) Ca2+ signals evoked by mixing of sperm with K8.6-HTF and RU1968F1. The final K+ 879 
concentration and pH after mixing was 51.25 mM and 8.1, respectively. (L) Dose-response relation of the data 880 
from (K) (IC50 = 1.7 μM).             881 
 882 
Figure 3: Action of RU1968F1 on progesterone-evoked Ca
2+ 
signals in single human sperm. (A) Changes in 883 
[Ca
2+
]i evoked by RU1968F1 in immobilized sperm. Sperm were challenged with RU1968F1 at t = 0. Traces 884 
represent averages of 122 (0 RU1968F1), 344 (1), 42, (3), 165, (10), and 109 (30) sperm from 3 donors. Signals 885 
are displayed as F-F0/Fmax-F0; F0 is the mean fluorescence of ≥ 5 images before application of RU1968F1; Fmax is 886 
the peak fluorescence signal evoked by ionomycin (not shown) to gauge the maximal response amplitude. (B) 887 
Progesterone-evoked Ca
2+
 responses (2 µM) in the absence and presence of RU1968F1 (30 µM); averages of 50 888 
(control) and 109 (RU1968F1) sperm from 3 donors. Progesterone and RU1968F1 were applied at t = 0; 889 
following application of RU1968F1, progesterone was applied at the time point indicated by the arrow. (C) 890 
Amplitude of progesterone-evoked Ca
2+
 responses in the absence and presence of different RU1968F1 891 
concentrations; averages of 122 (0 µm RU1968F1), 344 (1), 42 (3), 165 (10), 109 (30) sperm from 3 donors. (D) 892 
Mean amplitude of progesterone-evoked Ca
2+
 signals (2 µM) in the presence of RU1968F1; number of sperm: 893 
310 (0 µM RU1968F1), 552 (1), 181 (3) 302 (10), 222 (30). Error bars indicate SD. Fitting of a dose-response 894 
curve to the data yielded an IC50 of 4.8 ± 1.2 µM (standard error of the fit). 895 
 896 
Figure 4: Action of RU1968F1 on CatSper-mediated Ca
2+
 signals in mouse sperm populations. (A) Ca
2+
 897 
signals evoked by simultaneous mixing of mouse sperm with K8.6-TYH and RU1968F1 in a stopped-flow 898 
apparatus. After mixing, the final K
+
 concentration and pH was 69 mM and 8.1, respectively (B) Dose-response 899 
relation of the data from (A) (IC50 = 0.90 μM). (C) Ca
2+
 signals evoked by simultaneous mixing of mouse sperm 900 
with 8-Br-cAMP (20 mM) and RU1968F1. (D) Dose-response relation of the data from (C) (IC50 = 0.84 μM). 901 
Figure 5: Action of RU1968F1 on CatSper-mediated Ca
2+
 responses in sea urchin sperm. (A) Resact-902 
induced Ca
2+
 signals in sea urchin sperm evoked by simultaneous mixing of sperm with resact (20 pM) and 903 
RU1968F1 in a stopped-flow apparatus. (B) Dose-response relation of the data from (A) (IC50 = 0.7 μM). (C) 904 
Depolarization-induced Ca
2+
 signals evoked by mixing of sperm with KCl-ASW and RU1968F1. Final K
+
 905 
concentration after mixing was 108 mM. (D) Dose-response relation of the data from (C) (IC50 = 1.0 μM). (E) 906 
Alkaline-evoked Ca
2+
 signals in the presence of RU1968F1; the final NH4Cl concentration after mixing was 30 907 
mM. (F) Dose-response relation of the data from (E) (IC50 = 4.6 μM).  908 
 909 
 910 
 911 
 912 
 913 
 914 
 915 
Figure 6: RU1968F1 inhibits monovalent CatSper currents in human and mouse sperm. (A) Representative 916 
current-voltage relationship of CatSper currents recorded from a human sperm cell in divalent-free extracellular 917 
and intracellular solution (pH 7.4) in the absence and presence of increasing RU1968F1 concentrations. Voltage 918 
was stepped from -100 mV to +150 mV in increments of 10 mV. Inset: Voltage protocol. (B) Dose-response 919 
relation for the inhibition of human CatSper currents by RU1968F1 at +100 mV (IC50 = 0.4 ± 0.3 µM; n = 5). 920 
(C) Representative monovalent CatSper currents recorded from a human sperm cell before (control) and after 921 
perfusion with progesterone (2µM) and progesterone plus RU1968F1 (3µM), evoked by the voltage protocol 922 
shown in (A). The dotted red line indicates the current at 0 mV. (D) Monovalent CatSper currents recorded from 923 
a human sperm cell before (control) and after perfusion with NH4Cl (10 mM) and NH4Cl plus RU1968F1 924 
(3µM), evoked by the voltage protocol shown in (A). The dotted red line indicates the current at 0 mV. (E) Mean 925 
amplitudes of monovalent currents at +100 mV recorded in the presence of RU1968F1, progesterone (2 µM), 926 
progesterone plus RU1968F1, NH4Cl (10 mM), and NH4Cl plus RU1968F1. Amplitudes were normalized to that 927 
evoked in the absence of any drug (control, dashed line). Error bars indicate SD (n = 5). *P ˂ 0.05 versus 928 
control. Data were normalized only after performing the statistical analysis using one-way ANOVA (see 929 
Methods for details and explanations). (F) Representative CatSper currents recorded from a mouse sperm cell in 930 
divalent-free extracellular and intracellular solution (pH 7.2) in the absence and presence of increasing 931 
RU1968F1 concentrations. Voltage was ramped between -100 and +100 mV from a holding potential of 0 mV. 932 
Inset: Voltage protocol. (G) Dose-response relation for the inhibition of mouse CatSper currents at +100 mV 933 
(IC50 = 10 ± 1 µM, n = 3). Error bars indicate SD. (H) Currents in the presence of extracellular divalent ions 934 
(HS) and monovalent currents in divalent-fee conditions (control) recoded form a mouse sperm cell evoked at a 935 
pHi 8 before (control) and after perfusion with RU1968F1, using the voltage protocol shown in (F). (I) Currents 936 
recorded form a mouse sperm cell at pHi 7.2 before (control) and after perfusion with NH4Cl (30 mM) and 937 
NH4Cl plus RU1968F1, using the voltage protocol shown in (F). (J) Mean amplitudes of monovalent currents at 938 
+100 mV recorded form mouse sperm in the presence of RU1968F1, NH4Cl plus RU1968F1, and at pHi 8 in the 939 
presence of RU1968F1, using the voltage protocol shown in (F). Amplitudes were normalized to the monovalent 940 
currents evoked in the absence of any drug (control, dashed line). Error bars indicate SD. (n = 5). *P ˂ 0.05 941 
versus control. Data were normalized only after performing the statistical analysis using one-way ANOVA (see 942 
Methods for details and explanations). 943 
 944 
Figure 7: RU1968F1 inhibits human but not mouse Slo3. (A) Representative Slo3 currents in a mouse sperm 945 
cell, recorded in the presence of extracellular divalent ions at symmetric intra- and extracellular K
+
 946 
concentrations in the absence and presence of 50 µM RU1968F1. Inset: Voltage protocol. (B) Mean Slo3 947 
currents in mouse sperm at +100 mV in the absence and presence of 50 µM RU1968F1 (n = 5). (C) 948 
Representative Slo3 currents recorded from a human sperm cell in the absence and presence of RU1968F1. Inset: 949 
Voltage protocol. (D) Dose-response relation for the inhibition of human Slo3 currents by RU1968F1 at 950 
+100 mV (IC50 = 7 ± 6 µM, n = 4). Error bars indicate SD.  951 
 952 
Figure 8: RU1968F1 interferes with hyperactivation and abolishes progesterone-induced motility 953 
responses in human sperm. (A, B) Motility parameters of non-capacitated (A) and capacitated (B) human 954 
sperm in the absence and presence of RU1968F1 (n = 8); sperm were bathed in the drug for 300 s. Error bars 955 
indicate SD. *P ˂ 0.05 versus control (absence of RU1968F1). (C-E) Fraction of hyperactivated (C), motile (D), 956 
and progressively swimming (E) sperm after capacitation in the absence and presence of RU1968F1 (n = 11). 957 
Error bars indicate SD. *P ˂ 0.05 versus control (absence of RU1968F1). (F) Hyperactivation evoked by bathing 958 
sperm for 300 s in RU1968F1, progesterone, or progesterone plus RU1968F (n = 11). Error bars indicate SD. (G) 959 
Track of a single sperm cell recorded before (3 s, black), during (0.2 s, red), and after (2.8 s, blue) uncaging of 960 
progesterone. The arrow indicates the direction of movement. Inset: time course of the average path velocity 961 
(VAP); the red bar indicates the uncaging of progesterone. (H) Track of a single sperm cell recorded before (3 s, 962 
black), during (0.2 s, flash, red) and after (2.8 s, blue) uncaging of progesterone in the presence of RU1968F1 963 
(30 µM). Inset: time course of VAP; the red bar indicates the uncaging of progesterone. (I) Mean relative 964 
changes in VAP averaged over 20-30 sperm in the field of view after uncaging of progesterone (n = 11). Error 965 
bars indicate SD. *P ˂ 0.05 versus control (before flash, 0 s). Data were normalized only after performing the 966 
statistical analysis using one-way ANOVA (see Methods for details and explanations). 967 
 968 
Figure 9: RU1968F1 suppresses penetration of sperm into viscous media. (A) Number of sperm at a 969 
penetration distance of 2 cm in a modified Kremer's sperm-mucus penetration test. The sperm were incubated in 970 
buffer (control), progesterone, or progesterone plus RU1968F1 (n = 21). Error bars indicate SD. *P ˂ 0.05 versus 971 
control; 
#P ˂ 0.05 versus progesterone without RU1968F1. (B) Number of sperm after incubation in buffer 972 
(control) or RU1968F1 (n = 21). Error bars indicate SD. *P ˂ 0.05 versus control (n = 21). (C) Number of sperm 973 
when the sperm were bathed in buffer (control) or progesterone, in the absence (0) or presence of RU1968F1 in 974 
the capillary (n = 6). Error bars indicate SD. *P ˂ 0.05 versus control; #P ˂ 0.05 versus progesterone without 975 
RU1968F1. (D) Acrosome reaction evoked by RU1968F1, progesterone, or progesterone and RU1968F1 (n 976 
=10). Error bars indicate SD. *P ˂ 0.05 versus control, #P ˂ 0.05 versus progesterone. 977 
 978 
Figure 10: RU1968F1 abolishes chemotaxis of sea urchin sperm. (A) Dark‐field microscopy images of a 979 
sperm suspension before (top) and after (bottom) establishing a resact gradient by photolysis of caged resact 980 
(middle) in the absence (control, left panel) or presence of RU1968F1 (30 μM, right panel). RU1968F1 abolishes 981 
resact‐induced sperm accumulation. (B) Relative change of the sperm dispersion in the field of view evoked by 982 
uncaging of resact (t = 0, flash) in the absence (control, red) or presence of RU1968F1 (black); a decrease of 983 
dispersion indicates sperm accumulation in the irradiated area (control, n = 5, RU1968F1, n = 6). Error bars 984 
(grey) indicate SD.  985 
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